secwatch / observer
8-K filed June 9, 2025, 7:59 PM ET ticker FBLG CIK 0001958777
leadership confidence high sentiment neutral materiality 0.50

FibroBiologics appoints Jason D. Davis, CPA, as CFO; base salary $350k

FibroBiologics, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jason D. Davis

Chief Financial Officer
FBLG · FibroBiologics, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
On June 9, 2025, FibroBiologics, Inc. (the “Company”) announced that Jason D. Davis has been appointed as the Company’s Chief Financial Officer, effective as of June 9, 2025 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason D. Davis was appointed as Chief Financial Officer at FibroBiologics, Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On June 9, 2025, FibroBiologics, Inc. (the “Company”) announced that Jason D. Davis has been appointed as the Company’s Chief Financial Officer, effective as of June 9, 2025 (the “Effective Date”).
View on SEC.gov

FibroBiologics, Inc. filing history →

Source: SEC EDGAR
accession 0001641172-25-014296
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.